Detalhe da pesquisa
1.
Innate and Adaptive Immunity to Transfused Allogeneic RBCs in Mice Requires MyD88.
J Immunol
; 208(4): 991-997, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35039331
2.
Class switching is differentially regulated in RBC alloimmunization and vaccination.
Transfusion
; 63(4): 826-838, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36907655
3.
Poly(I:C) causes failure of immunoprophylaxis to red blood cells expressing the KEL glycoprotein in mice.
Blood
; 135(22): 1983-1993, 2020 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32266378
4.
The lysophospholipid-binding molecule CD1D is not required for the alloimmunization response to fresh or stored RBCs in mice despite RBC storage driving alterations in lysophospholipids.
Transfusion
; 61(7): 2169-2178, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34181769
5.
Characterization of circulating and cultured Tfh-like cells in sickle cell disease in relation to red blood cell alloimmunization status.
Transfus Apher Sci
; 59(4): 102778, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32439490
6.
Type 1 IFN signaling critically regulates influenza-induced alloimmunization to transfused KEL RBCs in a murine model.
Transfusion
; 59(10): 3243-3252, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31403208
7.
Type I IFN Is Necessary and Sufficient for Inflammation-Induced Red Blood Cell Alloimmunization in Mice.
J Immunol
; 199(3): 1041-1050, 2017 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28630094
8.
Antigen modulation as a potential mechanism of anti-KEL immunoprophylaxis in mice.
Blood
; 128(26): 3159-3168, 2016 12 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-27688803
9.
Bortezomib decreases the magnitude of a primary humoral immune response to transfused red blood cells in a murine model.
Transfusion
; 57(1): 82-92, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27734515
10.
B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice.
Transfusion
; 57(11): 2595-2608, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28836263
11.
Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells.
Transfusion
; 56(4): 863-72, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26643781
12.
Class switching is differentially regulated in RBC alloimmunization and vaccination.
bioRxiv
; 2023 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36712006
13.
FcγRIV is required for IgG2c mediated enhancement of RBC alloimmunization.
Front Immunol
; 13: 972723, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36189253
14.
Complement Plays a Critical Role in Inflammation-Induced Immunoprophylaxis Failure in Mice.
Front Immunol
; 12: 704072, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34249009
15.
Anti-KEL sera prevents alloimmunization to transfused KEL RBCs in a murine model.
Haematologica
; 100(10): e394-7, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26185172
16.
Transfused platelets enhance alloimmune responses to transfused KEL-expressing red blood cells in a murine model.
Blood Transfus
; 17(5): 368-377, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30418129
17.
Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses.
JCI Insight
; 3(22)2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30429364
18.
CD4 Depletion or CD40L Blockade Results in Antigen-Specific Tolerance in a Red Blood Cell Alloimmunization Model.
Front Immunol
; 8: 907, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28824633
19.
DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR.
Cell Rep
; 14(9): 2180-2192, 2016 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26923591
20.
mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation.
Cancer Cell
; 27(1): 41-56, 2015 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25584893